英国风湿病学会关于孕期及哺乳期用药的指南：风湿病实践中使用的合并症药物 - Suppr

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

作者信息

Schreiber Karen, Frishman Margreta, Russell Mark D, Dey Mrinalini, Flint Julia, Allen Alexander, Crossley Amy, Gayed Mary, Hodson Kenneth, Khamashta Munther, Moore Louise, Panchal Sonia, Piper Madeleine, Reid Clare, Saxby Katherine, Senvar Naz, Tosounidou Sofia, van de Venne Maud, Warburton Louise, Williams David, Yee Chee-Seng, Gordon Caroline, Giles Ian

机构信息

Thrombosis & Haemophilia Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Department of Rheumatology, Danish Hospital for Rheumatic Diseases, Sonderborg, Denmark.

出版信息

Rheumatology (Oxford). 2023 Apr 3;62(4):e89-e104. doi: 10.1093/rheumatology/keac552.

DOI:10.1093/rheumatology/keac552

PMID:36318967

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10070063/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6587/10070063/b2a39a0ac8ca/keac552f1.jpg

相似文献

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

Rheumatology (Oxford). 2023 Apr 3;62(4):e89-e104. doi: 10.1093/rheumatology/keac552.

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

Rheumatology (Oxford). 2023 Apr 3;62(4):1388-1397. doi: 10.1093/rheumatology/keac559.

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2023 Apr 3;62(4):e48-e88. doi: 10.1093/rheumatology/keac551.

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2023 Apr 3;62(4):1370-1387. doi: 10.1093/rheumatology/keac558.

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scope.

Rheumatology (Oxford). 2022 Feb 2;61(2):480-481. doi: 10.1093/rheumatology/keab600.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice.

Rheumatology (Oxford). 2016 Sep;55(9):1698-702. doi: 10.1093/rheumatology/kev405. Epub 2016 Jan 10.

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scope.

Rheumatology (Oxford). 2021 Aug 2;60(8):3565-3569. doi: 10.1093/rheumatology/keab334.

Medications in pregnancy and breastfeeding.

Best Pract Res Clin Obstet Gynaecol. 2020 Apr;64:68-76. doi: 10.1016/j.bpobgyn.2019.10.007. Epub 2019 Nov 15.

Antirheumatic medications in pregnancy and breastfeeding.

Curr Opin Rheumatol. 2020 May;32(3):238-246. doi: 10.1097/BOR.0000000000000710.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404. Epub 2016 Jan 10.

引用本文的文献

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey.

Ther Adv Musculoskelet Dis. 2025 Jul 16;17:1759720X251350087. doi: 10.1177/1759720X251350087. eCollection 2025.

Drug safety in pregnancy.

Aust Prescr. 2025 Feb;48(1):5-9. doi: 10.18773/austprescr.2025.008.

Current and future perspectives on pregnancy and lactation-associated osteoporosis.

Front Endocrinol (Lausanne). 2024 Dec 5;15:1494965. doi: 10.3389/fendo.2024.1494965. eCollection 2024.

Pregnancy- and Lactation-Associated Osteoporosis: A Literature Review Based on a Clinical Case.

Cureus. 2024 Nov 2;16(11):e72889. doi: 10.7759/cureus.72889. eCollection 2024 Nov.

Transient osteoporosis of the hip in pregnancy.

Obstet Med. 2024 Dec;17(4):188-193. doi: 10.1177/1753495X241236222. Epub 2024 Feb 28.

Kidney disease and reproductive health.

Nat Rev Nephrol. 2025 Feb;21(2):127-143. doi: 10.1038/s41581-024-00901-6. Epub 2024 Nov 5.

Migraine and Pregnancy.

Life (Basel). 2024 Sep 25;14(10):1224. doi: 10.3390/life14101224.

What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.

Int J Mol Sci. 2024 Sep 30;25(19):10559. doi: 10.3390/ijms251910559.

Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome.

J Clin Rheumatol. 2024 Oct 1;30(7S Suppl 1):S49-S55. doi: 10.1097/RHU.0000000000002128.

Risk Assessment and Optimization for Pregnancy in Patients with Rheumatic Diseases.

Diagnostics (Basel). 2024 Jul 2;14(13):1414. doi: 10.3390/diagnostics14131414.

本文引用的文献

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2023 Apr 3;62(4):e48-e88. doi: 10.1093/rheumatology/keac551.

Pre-pregnancy care and contraception - the two-sided coin of reproductive health and safe prescribing.

Obstet Med. 2021 Sep;14(3):127-128. doi: 10.1177/1753495X211037879. Epub 2021 Sep 13.

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scope.

Rheumatology (Oxford). 2021 Aug 2;60(8):3565-3569. doi: 10.1093/rheumatology/keab334.

Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis.

Exp Ther Med. 2021 Jan;21(1):57. doi: 10.3892/etm.2020.9489. Epub 2020 Nov 19.

Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis.

Pharmacol Res Perspect. 2020 Oct;8(5):e00644. doi: 10.1002/prp2.644.

The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.

Hum Reprod Update. 2020 Nov 1;26(6):961-1001. doi: 10.1093/humupd/dmaa022.

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

Arthritis Rheumatol. 2020 Apr;72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23.

Drug exposure during pregnancy and fetal cardiac function - a systematic review.

J Perinat Med. 2020 Mar 26;48(3):199-208. doi: 10.1515/jpm-2019-0402.

Clinical evidence of the effect of bisphosphonates on pregnancy and the infant.

Horm Mol Biol Clin Investig. 2019 Sep 20;40(2):/j/hmbci.2019.40.issue-2/hmbci-2019-0021/hmbci-2019-0021.xml. doi: 10.1515/hmbci-2019-0021.

The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis.

PLoS One. 2019 Jul 24;14(7):e0219732. doi: 10.1371/journal.pone.0219732. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

作者信息

机构信息

Thrombosis & Haemophilia Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Department of Rheumatology, Danish Hospital for Rheumatic Diseases, Sonderborg, Denmark.

出版信息

Rheumatology (Oxford). 2023 Apr 3;62(4):e89-e104. doi: 10.1093/rheumatology/keac552.

DOI:10.1093/rheumatology/keac552

PMID:36318967

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10070063/

Abstract

摘要

相似文献

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

Rheumatology (Oxford). 2023 Apr 3;62(4):e89-e104. doi: 10.1093/rheumatology/keac552.

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

Rheumatology (Oxford). 2023 Apr 3;62(4):1388-1397. doi: 10.1093/rheumatology/keac559.

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2023 Apr 3;62(4):e48-e88. doi: 10.1093/rheumatology/keac551.

Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2023 Apr 3;62(4):1370-1387. doi: 10.1093/rheumatology/keac558.

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scope.

Rheumatology (Oxford). 2022 Feb 2;61(2):480-481. doi: 10.1093/rheumatology/keab600.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: analgesics and other drugs used in rheumatology practice.

Rheumatology (Oxford). 2016 Sep;55(9):1698-702. doi: 10.1093/rheumatology/kev405. Epub 2016 Jan 10.

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scope.

Rheumatology (Oxford). 2021 Aug 2;60(8):3565-3569. doi: 10.1093/rheumatology/keab334.

Medications in pregnancy and breastfeeding.

Best Pract Res Clin Obstet Gynaecol. 2020 Apr;64:68-76. doi: 10.1016/j.bpobgyn.2019.10.007. Epub 2019 Nov 15.

Antirheumatic medications in pregnancy and breastfeeding.

Curr Opin Rheumatol. 2020 May;32(3):238-246. doi: 10.1097/BOR.0000000000000710.

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2016 Sep;55(9):1693-7. doi: 10.1093/rheumatology/kev404. Epub 2016 Jan 10.

引用本文的文献

Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey.

Ther Adv Musculoskelet Dis. 2025 Jul 16;17:1759720X251350087. doi: 10.1177/1759720X251350087. eCollection 2025.

Drug safety in pregnancy.

Aust Prescr. 2025 Feb;48(1):5-9. doi: 10.18773/austprescr.2025.008.

Current and future perspectives on pregnancy and lactation-associated osteoporosis.

Front Endocrinol (Lausanne). 2024 Dec 5;15:1494965. doi: 10.3389/fendo.2024.1494965. eCollection 2024.

Pregnancy- and Lactation-Associated Osteoporosis: A Literature Review Based on a Clinical Case.

Cureus. 2024 Nov 2;16(11):e72889. doi: 10.7759/cureus.72889. eCollection 2024 Nov.

Transient osteoporosis of the hip in pregnancy.

Obstet Med. 2024 Dec;17(4):188-193. doi: 10.1177/1753495X241236222. Epub 2024 Feb 28.

Kidney disease and reproductive health.

Nat Rev Nephrol. 2025 Feb;21(2):127-143. doi: 10.1038/s41581-024-00901-6. Epub 2024 Nov 5.

Migraine and Pregnancy.

Life (Basel). 2024 Sep 25;14(10):1224. doi: 10.3390/life14101224.

What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.

Int J Mol Sci. 2024 Sep 30;25(19):10559. doi: 10.3390/ijms251910559.

Reproductive Health in Scleroderma, Vasculitis, and Sjögren Syndrome.

J Clin Rheumatol. 2024 Oct 1;30(7S Suppl 1):S49-S55. doi: 10.1097/RHU.0000000000002128.

Risk Assessment and Optimization for Pregnancy in Patients with Rheumatic Diseases.

Diagnostics (Basel). 2024 Jul 2;14(13):1414. doi: 10.3390/diagnostics14131414.

本文引用的文献

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids.

Rheumatology (Oxford). 2023 Apr 3;62(4):e48-e88. doi: 10.1093/rheumatology/keac551.

Pre-pregnancy care and contraception - the two-sided coin of reproductive health and safe prescribing.

Obstet Med. 2021 Sep;14(3):127-128. doi: 10.1177/1753495X211037879. Epub 2021 Sep 13.

Prescribing anti-rheumatic drugs in pregnancy and breastfeeding-the British Society for Rheumatology guideline scope.

Rheumatology (Oxford). 2021 Aug 2;60(8):3565-3569. doi: 10.1093/rheumatology/keab334.

Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: A systematic review and meta-analysis.

Exp Ther Med. 2021 Jan;21(1):57. doi: 10.3892/etm.2020.9489. Epub 2020 Nov 19.

Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis.

Pharmacol Res Perspect. 2020 Oct;8(5):e00644. doi: 10.1002/prp2.644.

The effect of paternal exposure to immunosuppressive drugs on sexual function, reproductive hormones, fertility, pregnancy and offspring outcomes: a systematic review.

Hum Reprod Update. 2020 Nov 1;26(6):961-1001. doi: 10.1093/humupd/dmaa022.

2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

Arthritis Rheumatol. 2020 Apr;72(4):529-556. doi: 10.1002/art.41191. Epub 2020 Feb 23.

Drug exposure during pregnancy and fetal cardiac function - a systematic review.

J Perinat Med. 2020 Mar 26;48(3):199-208. doi: 10.1515/jpm-2019-0402.

Clinical evidence of the effect of bisphosphonates on pregnancy and the infant.

Horm Mol Biol Clin Investig. 2019 Sep 20;40(2):/j/hmbci.2019.40.issue-2/hmbci-2019-0021/hmbci-2019-0021.xml. doi: 10.1515/hmbci-2019-0021.

The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis.

PLoS One. 2019 Jul 24;14(7):e0219732. doi: 10.1371/journal.pone.0219732. eCollection 2019.

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献